trustme.bro/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Irrational drug design relies on empirical screening rather than structure-based mechanisms

the verdict
SUPPORTED
the evidence backs this
Recorded sources
3 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Empirical screening approaches, such as high-throughput screening, remain a cornerstone of lead identification and drug discovery alongside modern rational design methods.

The analysis

The claim states that empirical screening (such as high-throughput screening) is heavily relied upon rather than relying purely on structure-based mechanisms. The retrieved papers consistently describe empirical screening as a central, standard, or state-of-the-art approach in the pharmaceutical industry for lead identification, even as computational and rational design tools improve. Therefore, the claim is supported by the literature.

Evidence for · 3
Recorded source metadata

J. Major. Challenges and Opportunities in High Throughput Screening: Implications for New Technologies. 1998. https://doi.org/10.1177/108705719800300102

This study notes that while structural methods facilitate rational design, empirical screening continues to play a crucial role in lead identification through high-throughput testing.

See more details
More for · 2
Recorded source metadata

Geetha Singh. Modernizing Drug Discovery: Fusing Legacy Techniques with Next-Gen Innovations. 2025. https://doi.org/10.67238/jddr.2025.v1.03

This article highlights that modern drug discovery continues to evolve from traditional empirical approaches toward integrated methodologies.

Recorded source metadata

R. Paul Nobrega, Michael E. Brown, C. Williams, Christopher A Sumner, Patricia Estep, Isabelle Caffry, Yao Yu, Heather Lynaugh, Irina Burnina, A. Lilov, Jordan Desroches, J. Bukowski, Tingwan Sun, J. Belk, Kirt M. Johnson, Yingda Xu. Database-Centric Method for Automated High-Throughput Deconvolution and Analysis of Kinetic Antibody Screening Data. 2017. https://doi.org/10.1177/2472630317705611

This paper affirms that state-of-the-art industrial drug discovery relies on the empirical interrogation of a library of drug candidates against a target molecule.

The paper trail · every fact has a biography
first checked01 Aug 2026
judged → SUPPORTED · 8601 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.
trust me, bro: win the argument, pass the class, survive peer review.

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work · Dispute this receipt